Goldman Jonathan — SEC Form 4 filings

SEC reporting owner CIK 2013869. 5 Form 4 filings on record with FilingPulse; latest filed 2026-03-31.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-08-14 to 2026-03-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Avalo Therapeutics, Inc. (AVTX)Director52 legs · 11,367 sh · $162,9379

Form 4 filings — Goldman Jonathan

FiledFormIssuerReported transactionsSource
2026-03-314Avalo Therapeutics, Inc. (AVTX)Option exercise (M): 3,166 · Option exercise (M): 3,166 (derivative) @ $0EDGAR
2025-11-174Avalo Therapeutics, Inc. (AVTX)Sale (S): 3,167 @ $14.30 · Option exercise (M): 8,200 @ $9.88 · Sale (S): 8,200 @ $14.35 · Option exercise (M): 8,200 (derivative) @ $0EDGAR
2025-06-184Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 20,100 (derivative) @ $0EDGAR
2025-04-014Avalo Therapeutics, Inc. (AVTX)Option exercise (M): 3,167 · Option exercise (M): 3,167 (derivative) @ $0EDGAR
2024-08-144Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 24,600 (derivative) @ $0 · Grant/award (A): 9,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2013869 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →